Nasim Asadi Faezi
1 
, Pourya Gholizadeh
2 , Moussa Sanogo
3 , Amadou Oumarou
4 , Maad Nasser Mohamed
5 , Yacouba Cissoko
6 , Mamadou Saliou Sow
7 , Bakary Sayon Keita
8 , Youssouf AG Mohamed Baye
6,8, Pasquale Pagliano
9 , Patassi Akouda
10, Sid'Ahmed Soufiane
11 , Akory Ag Iknane
6,12 , Mamadou Oury Safiatou Diallo
7, Zakaria Gansane
13, Barkat Ali Khan
14 , Şükran Köse
15 , Hamid Allahverdipour
16 , Khudaverdi Ganvarov
17 , Mariam Soumaré
6, Mohammad Asgharzadeh
2 , Sounkalo Dao
6* , Hossein Samadi Kafil
2* 1 Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran
2 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 Faculty of Pharmacy USTTB, Faculty of Medicine and Odonto Stomatology, University of Science, Technics and Technology of Bamako, Bamako, Mali
4 Faculte des sciences la santé de l universite Dan Dicko DanKoulodo de Maradi, Niger
5 Service des maladies infectieuses et tropicales de l’hôpital général peltier, Djibouti
6 Faculty of Medicine and Odonto Stomatology (FMOS), USTTB, University of Science, Technics and Technology of Bamako, Bamako, Mali
7 Service des Maladies Infectieuses, Hôpital National Donka, CHU Conakry, Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG), Guinea
8 Department of Medicine and Medical Specialities/Infectious Disease Unit of Fousseyni Daou Hospital, Kayes, Mali
9 Departement of Medicine, University of Salerno, Salerno, Italy
10 CHU Sylvanus Olympio, Universitie delome, Togo
11 Faculte de Medecine de Nouakchott, Muritanie
12 Institut National de Santé Publique, Bamako, Mali
13 Burkinabé Observatory for Healthcare Quality and Safety, Ouagadougou, Burkina Faso
14 Department of Pharmaceutics, Faculty of Pharmacy, Gomal University, Dera Ismail Khan, Pakistan
15 Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Tepecik Training and Research Hospital, İzmir, Turkey
16 Research Center of Psychiatry and Behavioural Sciences and Department of Health Education and Promotion, Tabriz University of Medical Sciences, Tabriz, Iran
17 Department of Microbiology, Baku State University, Baku, Azerbaijan
Abstract
Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance.
Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participants’ attitudes and beliefs regarding vaccines, concerns, and vaccine hesitancy.
Results: Attitudes and beliefs relating to vaccines in general, and the COVID-19 vaccine, were ascertained. Overall, 66.81% of the contributors would like to be vaccinated against COVID-19, while %33.19 did not intend to be vaccinated. Reasons for COVID-19 vaccine hesitancy included concern regarding vaccine side effects, fear of getting sick from the uptake of the vaccine, and the absence of accurate vaccine promotion news. Individuals with higher education believe that India (68.6%) produces the best vaccine (P<0.001), while healthcare workers think the Chinese vaccine (44.2%) is the best (P=0.020). Individuals with higher education have not been vaccinated, not be healthcare workers, and females were the most contributors to effective of the vaccine in reducing mortality from COVID-19 disease.
Conclusion: Given the degree of hesitancy against COVID-19 vaccination, a multifaceted approach to facilitate vaccine uptake that includes vaccine education, behavioral change strategies, and health promotion, is paramount.